OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects
Mian Yu, Miaoqing Zhao, Rilei Yu, et al.
Journal of Controlled Release (2019) Vol. 304, pp. 242-258
Closed Access | Times Cited: 10
Mian Yu, Miaoqing Zhao, Rilei Yu, et al.
Journal of Controlled Release (2019) Vol. 304, pp. 242-258
Closed Access | Times Cited: 10
Showing 10 citing articles:
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
Christian Bailly, Xavier Thuru, Bruno Quesnel
NAR Cancer (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 201
Christian Bailly, Xavier Thuru, Bruno Quesnel
NAR Cancer (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 201
Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury
Lan Li, Yili Wang, Rui Guo, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 259-272
Open Access | Times Cited: 143
Lan Li, Yili Wang, Rui Guo, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 259-272
Open Access | Times Cited: 143
Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy
Jia-Ying Yang, Bo Sun, Xiaolu Wei, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 21
Jia-Ying Yang, Bo Sun, Xiaolu Wei, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 21
Role of Phytoconstituents in Cancer Treatment: A Review
Manish Kumar, Sakshi Gupta, Kamini Kalia, et al.
Recent Advances in Food Nutrition & Agriculture (2024) Vol. 15, Iss. 2, pp. 115-137
Closed Access | Times Cited: 3
Manish Kumar, Sakshi Gupta, Kamini Kalia, et al.
Recent Advances in Food Nutrition & Agriculture (2024) Vol. 15, Iss. 2, pp. 115-137
Closed Access | Times Cited: 3
Nanomedicine in the Diagnosis and Treatment of Pancreatic Cancer
Kexin Guo, Sicheng Li, Xinyu Wu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 449-449
Open Access
Kexin Guo, Sicheng Li, Xinyu Wu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 449-449
Open Access
Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy
Jianhua Chen, Eerdunbagena Ning, Zhijun Wang, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1389-1396
Open Access | Times Cited: 20
Jianhua Chen, Eerdunbagena Ning, Zhijun Wang, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1389-1396
Open Access | Times Cited: 20
Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer
Zhicheng Wang, Chao Sun, Haijun Wu, et al.
Materials Today Bio (2021) Vol. 13, pp. 100189-100189
Open Access | Times Cited: 19
Zhicheng Wang, Chao Sun, Haijun Wu, et al.
Materials Today Bio (2021) Vol. 13, pp. 100189-100189
Open Access | Times Cited: 19
Sequential receptor–mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment
Jingmin Shen, Chao Sun, Zhicheng Wang, et al.
International Journal of Pharmaceutics (2021) Vol. 601, pp. 120553-120553
Closed Access | Times Cited: 18
Jingmin Shen, Chao Sun, Zhicheng Wang, et al.
International Journal of Pharmaceutics (2021) Vol. 601, pp. 120553-120553
Closed Access | Times Cited: 18
Simultaneous Knockdown of Immune Suppressive Markers by Tumor Microenvironment-Responsive Multifaceted Prodrug Nanomedicine
Liuwei Zhang, Jingyun Wang, Hongyan Cui, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 10, pp. 12864-12881
Closed Access | Times Cited: 7
Liuwei Zhang, Jingyun Wang, Hongyan Cui, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 10, pp. 12864-12881
Closed Access | Times Cited: 7
CD13-specific ligand facilitates Xanthatin nanomedicine targeting dendritic cells for therapy of refractory allergic rhinitis
Xue Zheng, Chao Sun, Rilei Yu, et al.
International Journal of Pharmaceutics (2020) Vol. 577, pp. 119034-119034
Closed Access | Times Cited: 12
Xue Zheng, Chao Sun, Rilei Yu, et al.
International Journal of Pharmaceutics (2020) Vol. 577, pp. 119034-119034
Closed Access | Times Cited: 12
